HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Etsuhide Yamamoto Selected Research

Prognathism

5/2011Skeletal stability after mandibular setback surgery: comparisons among unsintered hydroxyapatite/poly-L-lactic acid plate, poly-L-lactic acid plate, and titanium plate.
10/2010Stress change on the temporomandibular joint in mandibular prognathism subjects with asymmetry after orthognathic surgery.
8/2010Position of mandibular canal and ramus morphology before and after sagittal split ramus osteotomy.
11/2009Assessment of ramus, condyle, masseter muscle, and occlusal force before and after sagittal split ramus osteotomy in patients with mandibular prognathism.
1/2009Changes in the duration of the chewing cycle in patients with skeletal class III with and without asymmetry before and after orthognathic surgery.
11/2008Horizontal changes in the condylar head after sagittal split ramus osteotomy with bent plate fixation.
10/2008The evaluation of surgical factors related to recovery period of upper lip hypoaesthesia after Le Fort I osteotomy.
3/2008Assessment of the relationship between the recovery of maximum mandibular opening and the maxillomandibular fixation period after orthognathic surgery.
3/2007Condylar and disc positions after sagittal split ramus osteotomy with and without Le Fort I osteotomy.
2/2007Evaluation of upper lip hypoesthesia with a trigeminal somatosensory-evoked potential following Le Fort I osteotomy in combination with mandibular osteotomy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Etsuhide Yamamoto Research Topics

Disease

16Prognathism
05/2011 - 12/2002
10Neoplasms (Cancer)
12/2011 - 05/2004
7Squamous Cell Carcinoma of Head and Neck
12/2011 - 11/2004
6Neoplasm Metastasis (Metastasis)
12/2011 - 11/2005
3Hypesthesia (Numbness)
01/2008 - 08/2003
3Congenital Abnormalities (Deformity)
01/2006 - 08/2003
1Disease Progression
12/2011
1Lymphatic Metastasis
09/2009
1Retrognathia
02/2007
1Muscular Dystrophies (Muscular Dystrophy)
01/2007
1Alveolar Bone Loss
10/2006
1Infections
09/2006
1Temporomandibular Joint Disorders (Temporomandibular Joint Disorder)
07/2006
1Mouth Neoplasms (Oral Cancer)
11/2005
1Tongue Neoplasms (Tongue Neoplasm)
02/2005

Drug/Important Bio-Agent (IBA)

3Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
12/2011 - 11/2005
3Urokinase Plasminogen Activator ReceptorsIBA
12/2011 - 11/2005
3Proteins (Proteins, Gene)FDA Link
10/2011 - 12/2005
2SERPIN-B5 (maspin)IBA
12/2011 - 07/2009
2nedaplatinIBA
02/2010 - 11/2004
2Docetaxel (Taxotere)FDA Link
02/2010 - 11/2004
1Indicators and Reagents (Reagents)IBA
10/2011
1Proliferating Cell Nuclear Antigen (PCNA)IBA
10/2011
1TitaniumIBA
05/2011
1CollagenIBA
10/2009
1Protease Inhibitors (Protease Inhibitor)IBA
07/2009
1SerpinsIBA
07/2009
1Cisplatin (Platino)FDA LinkGeneric
10/2007
1Serine Proteases (Serine Protease)IBA
11/2006
1beta-Lactamases (beta-Lactamase)IBA
09/2006
1Matrix Metalloproteinases (MMPs)IBA
07/2006
1aggrecanaseIBA
07/2006
1Cadherins (E-Cadherin)IBA
12/2005
1Vascular Endothelial Growth Factor CIBA
02/2005
1AcetoneIBA
02/2005
1Myosins (Myosin)IBA
05/2004
1beta-sitosterol oleateIBA
08/2003

Therapy/Procedure

11Osteotomy
01/2009 - 08/2003
7Sagittal Split Ramus Osteotomy
08/2010 - 12/2004
3Bite Force (Occlusal Forces)
11/2009 - 10/2006
2Induction Chemotherapy
02/2010 - 11/2004
2Neoadjuvant Therapy
09/2009 - 11/2004
2Drug Therapy (Chemotherapy)
09/2009 - 10/2007
2Mandibular Osteotomy
02/2007 - 12/2002
1Orthognathic Surgery
10/2010
1Therapeutics
11/2006
1Distraction Osteogenesis
08/2003